Ignite Creation Date:
2024-05-05 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00005096
Status:
COMPLETED
Last Update Posted:
2017-07-14
First Post:
2000-04-06
Brief Title:
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-12
Start Date Type:
ACTUAL
Primary Completion Date:
2002-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2002-06
Completion Date Type:
ACTUAL
First Submit Date:
2000-04-06
First Submit QC Date:
March 3 2004
Study First Post Date:
2004-03-04
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-12
Last Update Post Date:
2017-07-14
Last Update Post Date Type:
ACTUAL